GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$3.13M
Contract actions149
Awards / PIIDs131
Federal customers8
Contracting offices23
Average action$21.0K
Active fiscal years7
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $3.13M in net contract obligations to RESEARCH AND DIAGNOSTIC SYSTEMS, INC across 149 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

RESEARCH AND DIAGNOSTIC SYSTEMS, INC contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$87.9K
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$936.7K235
FY 2020$519.2K443−44.6%
FY 2021$1.09M305+109.2%
FY 2022$279.9K273−74.2%
FY 2023$133.1K111−52.4%
FY 2024$89.5K81−32.8%
FY 2025$87.9K62−1.7%

04 / Federal Customers

Which federal agencies buy from RESEARCH AND DIAGNOSTIC SYSTEMS, INC?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
7529$2.85M12191.0%
7523$121.0K63.9%
1406$70.4K12.2%
3600$32.3K21.0%
97HW$25.9K10.8%
7524$23.9K10.8%
1700$9.7K100.3%
7526$070.0%

05 / Contracting Offices

Which contracting offices buy from RESEARCH AND DIAGNOSTIC SYSTEMS, INC?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$1.45M76546.3%
325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING$1.04M31233.3%
334516ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING$239.2K1327.6%
541380TESTING LABORATORIES$165.5K915.3%
541714RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$90.2K532.9%
541690OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES$61.7K112.0%
339114DENTAL EQUIPMENT AND SUPPLIES MANUFACTURING$45.5K211.5%
325412PHARMACEUTICAL PREPARATION MANUFACTURING$30.0K111.0%
339112SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING$13.5K710.4%
325998ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING-$180110.0%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6810CHEMICALS$849.8K12127.1%
6505DRUGS AND BIOLOGICALS$822.3K52326.3%
6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$666.7K15321.3%
6640LABORATORY EQUIPMENT AND SUPPLIES$490.9K35615.7%
6509DRUGS AND BIOLOGICALS, VETERINARY USE$186.7K1816.0%
Q301MEDICAL- LABORATORY TESTING$101.7K813.2%
6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$14.5K910.5%

08 / Competition Pattern

How was RESEARCH AND DIAGNOSTIC SYSTEMS, INC’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Other / unknown$1.97M67
Competed under SAP$872.8K64
Not available for competition$236.0K14
Competed$51.6K4

09 / Recent Contract Awards

What contract actions were recorded most recently for RESEARCH AND DIAGNOSTIC SYSTEMS, INC?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
140D0425P0179Sep 18, 2025$70.4KDEPARTMENTAL OFFICES IBC ACQ SVCS DIRECTORATE (00004)3254146505

10 / Interpreting the Profile

How should you evaluate RESEARCH AND DIAGNOSTIC SYSTEMS, INC as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.